Poteligeo.com

Visit poteligeo.com
  • 5 months ago

    Last scanned

  • 13 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Poteligeo.com

Visit poteligeo.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

POTELIGEO® (mogamulizumab-kpkc) | Official Patient Website

Discover POTELIGEO (mogamulizumab-kpkc) for mycosis fungoides (MF) and Sézary syndrome (SS), two types of cutaneous T-cell lymphoma (CTCL).

Poteligeo.com thumbnail
Poteligeo.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Microsoft Corporation, which reserves the following IP addresses for poteligeo.com: 52.173.77.140. Moreover, DNS used with this website include ns1.markmonitor.com, ns2.markmonitor.com, ns3.markmonitor.com, ns4.markmonitor.com, ns5.markmonitor.com, ns6.markmonitor.com, ns7.markmonitor.com. Subnet identifier ranges from 52.145.0.0 to 52.191.255.255. Classless Inter-Domain Routing (CIDR) is 52.148.0.0/14, 52.152.0.0/13, 52.145.0.0/16, 52.146.0.0/15, 52.160.0.0/11. ARIN net type is Direct Allocation.

  • 5 months ago

    Last scanned

  • 13 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

  • Hosting Company

    Microsoft Corporation

  • IPs

    52.173.77.140

  • DNS

    ns1.markmonitor.com

    ns2.markmonitor.com

    ns3.markmonitor.com

    ns4.markmonitor.com

    ns5.markmonitor.com

    ns6.markmonitor.com

    ns7.markmonitor.com

Whois

OWNERSHIP

Domain & Keywords

The registrar of poteligeo.com is MarkMonitor Inc. and the name expires on 2025-01-26. Owner email is not available. Their country of residence is Japan.

  • CTCL
  • cutaneous t-cell lymphoma
  • poteligeo
  • mycosis fungoides treatment
  • mogamulizumab
  • sezary syndrome treatment
  • ctcl treatment

Websites similar to poteligeo.com